Nervgen Pharma Corp Stock Momentum Indicators Stochastic Relative Strength Index

NGEN Stock  CAD 2.90  0.10  3.33%   
NervGen Pharma momentum indicators tool provides the execution environment for running the Stochastic Relative Strength Index indicator and other technical functions against NervGen Pharma. NervGen Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the Stochastic Relative Strength Index indicator function is designed to identify and follow existing trends. Momentum indicators of NervGen Pharma are pattern recognition functions that provide distinct formation on NervGen Pharma potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify the following input to run this model: Time Period, Fast-K Period, Fast-D Period, and Fast-D MA.

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Stochastic Relative Strength Index compares NervGen Pharma closing price in relationship to its price range over a given period of time. When the NervGen Pharma Corp SRSI reaches up above the upper threshold line, the equity is considered overbought with anticipation a reversal of NervGen Pharma trend.

NervGen Pharma Technical Analysis Modules

Most technical analysis of NervGen Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NervGen from various momentum indicators to cycle indicators. When you analyze NervGen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About NervGen Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NervGen Pharma Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of NervGen Pharma Corp based on widely used predictive technical indicators. In general, we focus on analyzing NervGen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NervGen Pharma's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of NervGen Pharma's intrinsic value. In addition to deriving basic predictive indicators for NervGen Pharma, we also check how macroeconomic factors affect NervGen Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Net Debt To EBITDA1.331.10.651.07
Intangibles To Total Assets0.02640.01810.03930.0746
Hype
Prediction
LowEstimatedHigh
0.142.868.76
Details
Intrinsic
Valuation
LowRealHigh
0.122.318.21
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Momentum Idea
Momentum
Invested over 50 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Driverless Cars Idea
Driverless Cars
Invested over 50 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Impulse Idea
Impulse
Invested few shares
FinTech Idea
FinTech
Invested few shares
Trump Equities Idea
Trump Equities
Invested few shares
Investing Idea
Investing
Invested few shares

Additional Tools for NervGen Stock Analysis

When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.